Showing results (1-10 of 94) with videos related to
Sort By:
Pageof 10
Journal of Clinical Medicine|July 12, 2025
Transthyretin Amyloid Cardiomyopathy-2025 Update: Current Diagnostic Approaches and Emerging Therapeutic OptionsCarsten Tschöpe, Ahmed Elsanhoury, Arnt V KristenCardiovascular Research|July 12, 2005
Endothelin-1 inhibits the neuronal norepinephrine transporter in hearts of male ratsJohannes Backs, Elke Bresch, Matthias Lutz, et al.Journal of Clinical Medicine|January 10, 2026
Left Bundle Branch Area Pacing in Transthyretin Cardiac Amyloidosis: A Narrative ReviewMaria Herrera Bethencourt, Arnt V Kristen, Vincent Algalarrondo, et al.Neurodegenerative Disease Management|November 28, 2018
Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosisArnt V Kristen, Senda Ajroud-Driss, Isabel Conceição, et al.Journal of Cardiovascular Translational Research|March 7, 2015
Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosisThibaud Damy, Daniel P Judge, Arnt V Kristen, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 9, 2018
Peak V'O<sub>2</sub> is an independent predictor of survival in patients with cardiac amyloidosisSelina Hein, Fabian Aus Dem Siepen, Ralf Bauer, et al.Plos One|April 7, 2017
Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis - Report from the Transthyretin Amyloidosis Outcome Survey (THAOS)Arnt V Kristen, Mathew S Maurer, Claudio Rapezzi, et al.Journal of Cardiac Failure|September 6, 2006
Preserved norepinephrine reuptake but reduced sympathetic nerve endings in hypertrophic volume-overloaded rat heartsArnt V Kristen, Michael M Kreusser, Lorenz Lehmann, et al.Pageof 10